Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27716434 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL14097235 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL28188990 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL10407022 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL21114427 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL29065831 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL14874595 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL1864784 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| SCHEMBL11705765 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9THRB | |
| Bromide SCHEMBL10879596 | 0.97 | CA12 (0.46) | CA12CA1CA2CA9THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1703199-A | Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin | IDEA AG (DE) | 2005-11-30 | — | — | CN | claimed |
| CN-118255914-A | Copolymer having carbosiloxane dendrimer structure, and composition, cosmetic raw material, film-forming agent and cosmetic containing the copolymer | 陶氏东丽株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-111093615-B | Aqueous gelling agent-containing cleansing composition for skin or hair, aqueous gelling agent, and method for producing cleansing composition | 株式会社ADEKA | 2023-04-18 | — | — | CN | disclosed |
| EP-2492301-B1 | NOVEL CO-MODIFIED ORGANOPOLYSILOXANE | DOW TORAY CO LTD (JP) | 2023-03-29 | — | — | EP | disclosed |
| CN-114949237-A | Vesicle | 斯昆申技术控股有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-108137820-B | Cosmetic composition, cosmetic and external preparation for skin | 陶氏东丽株式会社 | 2022-05-27 | — | — | CN | disclosed |
| CN-113527115-A | Anti-oral tumor pH sensitive intelligent material and application thereof | 四川大学 | 2021-10-22 | — | — | CN | disclosed |
| US-20210188883-A1 | HYDROPHILIC SILANES | DOW TORAY CO., LTD. (JP) | 2021-06-24 | — | — | US | disclosed |
| CN-106750749-B | Silicon dioxide-based opening agent for polyolefin film and preparation method thereof | 黄山贝诺科技有限公司 | 2020-11-10 | — | — | CN | disclosed |
| CN-107669564-B | Skin care composition with functions of repairing and regenerating, moisturizing and delaying senescence | 江少卿 | 2020-10-16 | — | — | CN | disclosed |
| WO-2011068250-A1 | LINEAR AND CYCLIC SILOXANES AND COSMETIC COMPOSITIONS MADE THEREOF | DOW CORNING TORAY CO., LTD. (JP) | 2011-06-09 | — | — | WO | disclosed |
| CN-1703199-B | Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin | IDEA AG | 2010-04-28 | — | — | CN | disclosed |
| US-20100028391-A1 | Cosmetics Comprising A Modified Organopolysiloxane | DOW CORNING TORAY COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-1895979-A1 | COSMETICS COMPRISING A MODIFIED ORGANOPOLYSILOXANE | Dow Corning Toray Co., Ltd. (JP) | 2008-03-12 | — | — | EP | disclosed |
| EP-1868657-A1 | DEODORIZING COMPOSITIONS FOR BIOWAST | Bioneutral Laboratories Corporation USA (US) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006137576-A1 | COSMETICS COMPRISING A MODIFIED ORGANOPOLYSILOXANE | DOW CORNING TORAY CO., LTD. (JP) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006137821-A1 | DEODORIZING COMPOSITIONS FOR BIOWAST | BIONEUTRAL LABORATORIES CORPORATION USA (US) | 2006-12-28 | — | — | WO | disclosed |
| US-20060228323-A1 | Compositions for treating and removing noxious materials malodors and microbes, and methods of use and preparation thereof | BIONEUTRAL LABORATORIES CORPORATION USA | 2006-10-12 | — | — | US | disclosed |
| CN-1703199-A | Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin | IDEA AG (DE) | 2005-11-30 | — | — | CN | disclosed |
| US-6258335-B1 | WITH RIBULOSE 1,5-BIPHOSPHATE IN SITU CONVERSION TO 3-PHOSPHOGLYCERALDEHYDE; CONTROLLING CARBON DIOXIDE EMISSION | BHATTACHARYA SANJOY KUMAR (US) | 2001-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028391-A1 | Cosmetics Comprising A Modified Organopolysiloxane | H1-0, H1-2, CHRM1 | CA12 931/4885CA1 917/4885CA2 1057/4885 |
| US-20210188883-A1 | HYDROPHILIC SILANES | H1-4, H1-2, ITGA4 | CA12 1650/4885CA1 2117/4885CA2 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.